---

---

tags : Antibody    symbols : JNJ   

save search

---

Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K |

Health Technology

| -7.83% | O: 0.99% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 52K |

Health Technology

| 0.33% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $97.28 2.27% 1.21% 3.5M |

Health Technology

| 3.11% | O: 0.52% H: 0.0% C: 0.0%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -4.13% | O: 1.32% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% -0.58% 2.1M |

Health Technology

| -4.07% | O: 0.02% H: 0.51% C: -0.3%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| -5.03% | O: 0.28% H: 1.71% C: -0.3%
BMY | $48.99 -0.31% 0.41% 7.1M |

Health Technology

| -8.0% | O: 0.26% H: 2.03% C: 1.57%
AMGN | News | $273.54 0.6% 0.65% 1.9M |

Health Technology

| -4.46% | O: 0.54% H: 0.0% C: 0.0%
antibody research global

---

Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published: 2024-03-15 (Crawled : 14:30) - prnewswire.com
TAK | News | $13.38 0.15% 1.94% 1.7M |

Health Technology

| -6.94% | O: 0.21% H: 0.97% C: 0.7%
NVS | News | $97.28 2.27% 1.21% 3.5M |

Health Technology

| 0.74% | O: 0.05% H: 0.14% C: -0.93%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -6.92% | O: -1.58% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| -2.85% | O: -0.7% H: 0.73% C: -0.16%
ABBV | News | $169.54 0.98% 0.18% 3.2M |

Health Technology

| -5.97% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M |

Health Technology

| -2.83% | O: -0.02% H: 0.0% C: 0.0%
REGN | News | $907.32 0.8% 0.74% 220K |

Health Technology

| -5.39% | O: -0.27% H: 1.26% C: 0.84%
AMGN | News | $273.54 0.6% 0.65% 1.9M |

Health Technology

| 0.74% | O: 0.2% H: 1.14% C: -1.18%
antibody therapeutics market

---

Global Therapeutic Antibody Market Research Report 2024: Monoclonal, Bispecific, Drug Conjugates, Others Insights and Forecasts 2019-2029
Published: 2024-02-28 (Crawled : 03:00) - prnewswire.com
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -6.47% | O: 0.67% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| -3.39% | O: -0.36% H: 0.1% C: -0.6%
ABBV | News | $169.54 0.98% 0.18% 3.2M |

Health Technology

| -5.16% | O: 0.6% H: 0.02% C: -1.03%
drug report antibody research global market

---

J&J Touts Positive Phase III Results for Antibody in Autoimmune Disorders
Published: 2024-02-06 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -4.37% | O: -0.49% H: 0.0% C: 0.0%
antibody positive disorders results

---

Antibody Therapeutics Market Size to Grow USD 364180 Million by 2029 at a CAGR of 11% | Valuates Reports
Published: 2024-01-21 (Crawled : 16:20) - prnewswire.com
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| Email alert Add to watchlist
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| Email alert Add to watchlist
antibody million therapeutics market

---

Antibody Therapeutics Market Worth $479.0 Billion | MarketsandMarkets
Published: 2023-12-07 (Crawled : 15:30) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480 |

Health Technology

| 2.32% | O: -1.66% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 1.21% 3.5M |

Health Technology

| 1.87% | O: -0.97% H: 0.3% C: -0.19%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -5.6% | O: -1.61% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% 0.18% 3.2M |

Health Technology

| 16.97% | O: 1.97% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M |

Health Technology

| 1.71% | O: -1.19% H: 0.0% C: 0.0%
REGN | News | $907.32 0.8% 0.74% 220K |

Health Technology

| 8.56% | O: 0.51% H: 1.22% C: 1.09%
IMNM | $14.66 -4.06% -4.37% 810K |

Health Technology

| 86.99% | O: -0.64% H: 1.67% C: -1.16%
BIIB | $193.18 -0.48% -0.48% 1.2M |

Health Technology

| -17.4% | O: 1.67% H: 0.91% C: 0.57%
antibody therapeutics market

---

Monoclonal Antibodies: A Transformative Force in Biopharmaceuticals, Driving Growth in Antibody Discovery Services and Platforms
Published: 2023-10-19 (Crawled : 17:00) - prnewswire.com
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -2.01% | O: -0.73% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| 21.71% | O: -1.17% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M |

Health Technology

| -12.43% | O: -2.42% H: 0.0% C: 0.0%
IMAB | $1.8 0.55% 200K |

Health Technology

| 36.36% | O: -0.76% H: 3.05% C: -0.38%
services antibody growth

---

Global Monoclonal Antibody Diagnostic Reagent Market Report 2023-2028: North America Leads the Way, Asia Pacific Emerges as a Growing Powerhouse
Published: 2023-10-13 (Crawled : 17:00) - prnewswire.com
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -3.9% | O: 0.64% H: 0.0% C: 0.0%
BIO | $285.28 1.84% 0.0% 250K |

Health Technology

| -17.71% | O: -0.67% H: 1.34% C: 0.11%
BDX | $234.36 0.21% 0.07% 570K |

Health Technology

| -8.83% | O: -0.08% H: 1.16% C: 0.72%
ABCM | News | $23.99 0.0% 7.4M |

Health Technology

| 5.92% | O: 0.2% H: 0.0% C: 0.0%
america report antibody diagnostic global asia growing market

---

J&J Snags FDA Approval for Second Multiple Myeloma Bispecific Antibody
Published: 2023-08-10 (Crawled : 14:20) - biospace.com/
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -13.35% | O: 0.75% H: 1.13% C: -1.05%
fda antibody approval

---

LAVA Therapeutics Announces Selection by Janssen of Lead Gamma-Delta T-Cell Engager Bispecific Antibody to Move Toward Clinical Development
Published: 2023-06-01 (Crawled : 20:00) - globenewswire.com
LVTX | $2.98 4.56% 4.68% 110K |

| 56.84% | O: 23.16% H: 61.97% C: 11.11%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -3.16% | O: 0.12% H: 1.67% C: 1.45%
antibody t-cell therapeutics

---

Janssen Reports First Results from Phase 2 SunRISe-1 Study of TAR-200 and Anti- PD-1 Antibody Cetrelimab in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer
Published: 2023-04-30 (Crawled : 20:20) - prnewswire.com
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -8.58% | O: -0.06% H: 0.43% C: 0.0%
tar-200 antibody bladder cancer results study

---

Leyden Labs’ Intranasal PanFlu Antibody Enters the Clinic
Published: 2023-04-19 (Crawled : 12:20) - biospace.com/
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -7.05% | O: 0.61% H: 0.43% C: 0.33%
antibody

---

Glycotope Presents GlycoTarget Platform and New Data on Platform-Derived anti-LYPD3 Antibody at 2022 Society for Immunotherapy of Cancer (SITC) Meeting Glycotope GmbH announces that it will present new...
Published: 2022-11-08 (Crawled : 09:00) - biospace.com/
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -12.76% | O: 0.97% H: 0.0% C: 0.0%
immunotherapy antibody meeting cancer platform

---

U.S. FDA Approves TECVAYLI™ (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-10-25 (Crawled : 22:00) - biospace.com/
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -12.2% | O: -0.06% H: 0.0% C: 0.0%
treatment fda antibody t-cell

---

Bavarian Nordic’s COVID-19 Booster Vaccine Candidate Demonstrates Durable Antibody Response Six Months After Vaccination in Phase 2 Clinical Trial
Published: 2022-10-17 (Crawled : 07:00) - globenewswire.com
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -8.89% | O: 0.63% H: 0.0% C: 0.0%
covid-19 candidate antibody vaccine six trial response phase 2

---

Roche launches its next-generation SARS-CoV-2 Rapid Antibody Test
Published: 2022-10-03 (Crawled : 06:00) - prnewswire.com
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -9.46% | O: -0.6% H: 0.05% C: -0.66%
test antibody rapid roche sars-cov-2

---

Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab in Heavily Pretreated Patients with Multiple Myeloma
Published: 2022-06-10 (Crawled : 13:00) - biospace.com/
GNMSF | News | $290.34 0.23% 3.83% 340 |

Health Technology

| -2.65% | O: -4.41% H: 3.01% C: 0.79%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -15.47% | O: -2.85% H: 0.0% C: 0.0%
GMAB | News | $28.56 -1.42% -1.51% 530K |

Health Technology

| -6.36% | O: -5.18% H: 0.0% C: 0.0%
AMGN | News | $273.54 0.6% 0.65% 1.9M |

Health Technology

| 11.4% | O: -2.34% H: 0.0% C: 0.0%
antibody results

---

Monoclonal Antibodies Market to hit USD 425 Billion by 2028, Says Global Market Insights Inc.
Published: 2022-05-17 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 2.6K |

Health Technology

| -28.29% | O: -0.92% H: 0.0% C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 52K |

Health Technology

| 33.15% | O: 0.55% H: 0.0% C: 0.0%
TAK | News | $13.38 0.15% 1.94% 1.7M |

Health Technology

| -6.42% | O: 0.21% H: 0.42% C: 0.14%
NVS | News | $97.28 2.27% 1.21% 3.5M |

Health Technology

| 14.01% | O: 1.63% H: 0.0% C: 0.0%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -15.39% | O: 1.08% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% -0.58% 2.1M |

Health Technology

| -5.89% | O: 1.71% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% 0.04% 1.4M |

Health Technology

| 150.64% | O: 1.74% H: 1.13% C: 0.47%
ABBV | News | $169.54 0.98% 0.18% 3.2M |

Health Technology

| 9.85% | O: 0.46% H: 0.0% C: 0.0%
market antibody

---

Global RSV Vaccine and Antibody Pipeline Market: Compound Annual Growth of 38.9% Forecast During 2024-2028
Published: 2022-05-16 (Crawled : 19:00) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 1.5K |

Health Technology

| 10.84% | O: 4.22% H: 0.0% C: -2.05%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -15.39% | O: 1.08% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M |

Health Technology

| -9.53% | O: 1.5% H: 0.64% C: 0.19%
AZN | News | $70.85 1.03% 1.02% 4.9M |

Health Technology

| 11.63% | O: 3.17% H: 0.0% C: 0.0%
antibody vaccine growth

---

Global Research Antibodies Market Analysis Report 2022-2027: Focus on Monoclonal Antibodies (mAbs), Polyclonal Antibodies (pAbs), Oncology, Infectious Diseases, Immunology, Neurology
Published: 2022-05-04 (Crawled : 13:00) - prnewswire.com
IPA | $1.22 -2.4% -0.81% 39K |

Professional, Scientific, and T...

| -78.29% | O: -1.25% H: 3.51% C: 1.08%
TMO | News | $574.59 4.78% 3.34% 2.2M |

Health Technology

| 3.55% | O: -0.67% H: 4.31% C: 3.8%
JNJ | News | $149.56 0.3% -0.17% 6.9M |

Health Technology

| -16.2% | O: -0.24% H: 0.0% C: 0.0%
BIO | $285.28 1.84% 0.0% 250K |

Health Technology

| -43.89% | O: -2.22% H: 3.83% C: 3.31%
ABCM | News | $23.99 0.0% 7.4M |

Health Technology

| 55.07% | O: -3.04% H: 3.27% C: 2.13%
research report market antibody

---

Gainers vs Losers

77%

23%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 26M |

AGBA | $2.97 137.6% 57.48% 66M |

Finance

EDBL | News | $6.59 75.27% 41.8% 2M |

ZAPP | $4.44 50.2% 33.12% 370K |

n/a

MTC | $2.24 43.59% 30.67% 6M |

Technology Services

OPRT | News | $3.15 40.0% 29.13% 12M |

Finance

SHIM | $3.045 35.33% 26.23% 870K |

HKIT | $1.33 30.39% 24.16% 390K |

Technology Services

ABVC | $1.35 29.81% 23.53% 7.1M |

Wholesale Trade

OST | $0.5 25.0% 21.88% 280K |

---

Your saved searches

---